301206 三元生物
按盤價 
26.930 +0.230 (+0.861%)
26.930 +0.230 (+0.861%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.531 | 2.325 | 1.223 | 5.778 | 68.853 |
| 總資產報酬率 ROA (%) | 1.451 | 2.184 | 1.157 | 5.033 | 44.331 |
| 投入資產回報率 ROIC (%) | 1.488 | 2.233 | 1.177 | 5.209 | 47.606 | 邊際利潤分析 |
| 銷售毛利率 (%) | 16.153 | 11.106 | 3.050 | 14.055 | 41.991 |
| 營業利潤率 (%) | 16.338 | 17.947 | 11.709 | 27.567 | 36.994 |
| 息稅前利潤/營業總收入 (%) | 15.217 | 16.577 | 10.205 | 18.896 | 37.282 |
| 淨利潤/營業總收入 (%) | 14.133 | 14.722 | 11.208 | 24.253 | 31.959 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 32.548 | 14.140 | -87.357 | 49.978 | 98.712 |
| 價值變動淨收益/利潤總額(%) | 66.002 | 84.692 | 189.989 | 46.829 | 0.041 |
| 營業外收支淨額/利潤總額(%) | -0.017 | 0.203 | 0.566 | -1.140 | 0.020 | 償債能力分析 |
| 流動比率 (X) | 21.084 | 13.904 | 1.435 | 3.226 | 1.426 |
| 速動比率 (X) | 19.759 | 13.319 | 0.970 | 2.759 | 1.228 |
| 資產負債率 (%) | 3.725 | 6.535 | 5.666 | 5.116 | 36.033 |
| 帶息債務/全部投入資本 (%) | 0.710 | 1.990 | 3.433 | 2.212 | 29.487 |
| 股東權益/帶息債務 (%) | 13,800.027 | 4,850.041 | 2,783.689 | 4,380.713 | 233.765 |
| 股東權益/負債合計 (%) | 2,584.236 | 1,430.123 | 1,664.855 | 1,854.666 | 177.527 |
| 利息保障倍數 (X) | -13.610 | -11.787 | -6.498 | -2.260 | 132.862 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 52.949 | 49.886 | 46.746 | 51.305 | 22.808 |
| 存貨周轉天數 (天) | 96.540 | 70.167 | 74.750 | 64.836 | 33.406 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
